Skip to main content
Log in

Tracking down tissues

  • News Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

FDA inspections of tissue banks remain a work in progress, and no clear path yet exists for procuring human tissues for biomedicine or drug development. Emily Waltz investigates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Waltz, E. Nat. Med. 12, 487–488 (2006).

    Article  CAS  Google Scholar 

  2. Human Tissue Task Force. 2007 Report (Department of Health & Human Services, Public Health Service, Food and Drug Administration, Bethesda, Maryland, USA, 2007). <http://www.fda.gov/cber/tissue/httf07report.htm>.

  3. Waltz, E. Nat. Med. 13, 391 (2007).

    Article  CAS  Google Scholar 

  4. National Institutes of Health Revitalization Act of 1993 <http://www.hhs.gov/ohrp/humansubjects/guidance/publiclaw103-43.htm>.

  5. Anonymous. Taken without consent. The Guardian 31 January (2001) <http://society.guardian.co.uk/alderhey/comment/0,431159,00.html>.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waltz, E. Tracking down tissues. Nat Biotechnol 25, 1204–1206 (2007). https://doi.org/10.1038/nbt1107-1204

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1107-1204

  • Springer Nature America, Inc.

This article is cited by

Navigation